Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
clinical trials
eli lilly
6
×
europe blog main
6
×
fda
6
×
life sciences
national blog main
boston blog main
boston top stories
europe top stories
national top stories
new york blog main
abbvie
allergan
cancer
indiana blog main
indiana top stories
merck
national
new york top stories
san francisco blog main
alzheimer's disease
amgen
black diamond therapeutics
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe
glaxosmithkline
incyte
moderna
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
What
drug
fda
bio
black
companies
diamond
leading
medicines
new
roundup
therapeutics
treatment
adults
alkermes
allergan
alliance
antipsychotic
approval
approved
benefits
bid
biotech
boehringer
bristol
buy
calls
cancer
caveats
changing
class
clinic
color
commonly
continue
crispr
days
debut
designed
diabetes
diamond’s
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines